ZFP41
gene geneOn this page
Also known as FLJ38705FLJ00028ZNF753
Summary
ZFP41 (ZFP41 zinc finger protein, HGNC:26786) is a protein-coding gene on chromosome 8q24.3, encoding Zinc finger protein 41 homolog (Q8N8Y5). A putative DNA-binding regulatory protein associated with meiosis in spermatogenesis.
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 286128 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 57 total
- MANE Select transcript:
NM_173832
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26786 |
| Approved symbol | ZFP41 |
| Name | ZFP41 zinc finger protein |
| Location | 8q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ38705, FLJ00028, ZNF753 |
| Ensembl gene | ENSG00000181638 |
| Ensembl biotype | protein_coding |
| Entrez | 286128 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000330701, ENST00000517702, ENST00000520584, ENST00000522233, ENST00000883739, ENST00000883740, ENST00000883741, ENST00000883742
RefSeq mRNA: 2 — MANE Select: NM_173832
NM_001271156, NM_173832
CCDS: CCDS6397
Canonical transcript exons
ENST00000330701 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001520791 | 143259775 | 143262705 |
| ENSE00002090429 | 143246939 | 143247142 |
| ENSE00003661488 | 143249690 | 143251340 |
Expression profiles
Bgee: expression breadth ubiquitous, 199 present calls, max score 89.19.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.2247 / max 68.7528, expressed in 1729 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 91394 | 7.2247 | 1729 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 89.19 | gold quality |
| sural nerve | UBERON:0015488 | 82.68 | gold quality |
| sperm | CL:0000019 | 81.33 | silver quality |
| stromal cell of endometrium | CL:0002255 | 80.11 | gold quality |
| cortical plate | UBERON:0005343 | 78.56 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.14 | silver quality |
| hypothalamus | UBERON:0001898 | 77.97 | gold quality |
| ventricular zone | UBERON:0003053 | 77.90 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 77.80 | gold quality |
| right frontal lobe | UBERON:0002810 | 77.75 | gold quality |
| islet of Langerhans | UBERON:0000006 | 77.59 | gold quality |
| tibia | UBERON:0000979 | 77.17 | gold quality |
| prefrontal cortex | UBERON:0000451 | 76.91 | gold quality |
| apex of heart | UBERON:0002098 | 76.82 | gold quality |
| granulocyte | CL:0000094 | 76.81 | gold quality |
| primary visual cortex | UBERON:0002436 | 76.57 | gold quality |
| neocortex | UBERON:0001950 | 76.40 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 76.26 | gold quality |
| lower esophagus | UBERON:0013473 | 76.25 | gold quality |
| amygdala | UBERON:0001876 | 76.15 | gold quality |
| frontal cortex | UBERON:0001870 | 75.97 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 75.95 | silver quality |
| left ovary | UBERON:0002119 | 75.70 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 75.64 | gold quality |
| ganglionic eminence | UBERON:0004023 | 75.57 | gold quality |
| right ovary | UBERON:0002118 | 75.53 | gold quality |
| body of uterus | UBERON:0009853 | 75.47 | gold quality |
| cerebral cortex | UBERON:0000956 | 75.42 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 75.37 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 75.31 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.73 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
122 targeting ZFP41, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-1193 | 100.00 | 65.93 | 529 |
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-1976 | 99.74 | 65.48 | 1127 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-4530 | 99.69 | 66.47 | 1509 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-670-5P | 99.67 | 69.94 | 1565 |
| HSA-MIR-6762-3P | 99.66 | 66.94 | 1188 |
| HSA-MIR-3158-5P | 99.65 | 67.51 | 1763 |
| HSA-MIR-7150 | 99.62 | 66.80 | 1322 |
| HSA-MIR-6836-5P | 99.60 | 65.62 | 1538 |
| HSA-MIR-6132 | 99.60 | 65.83 | 1554 |
Literature-anchored findings (GeneRIF, showing 1)
- Combining a glycolysis-related prognostic model based on scRNA-Seq with experimental verification identifies ZFP41 as a potential prognostic biomarker for HCC. (PMID:38516783)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:dkey-210j14.3 | ENSDARG00000089883 |
| danio_rerio | si:dkey-210j14.4 | ENSDARG00000090871 |
| danio_rerio | si:ch211-284e13.5 | ENSDARG00000094725 |
| danio_rerio | si:ch1073-224n8.1 | ENSDARG00000104485 |
| danio_rerio | znf16l | ENSDARG00000105532 |
| mus_musculus | Zfp41 | ENSMUSG00000047003 |
| rattus_norvegicus | Zfp41 | ENSRNOG00000007489 |
Paralogs (18): ZNF430 (ENSG00000118620), ZNF92 (ENSG00000146757), ZNF66 (ENSG00000160229), ZNF22 (ENSG00000165512), ZNF680 (ENSG00000173041), ZNF114 (ENSG00000178150), ZNF730 (ENSG00000183850), ZNF479 (ENSG00000185177), ZNF626 (ENSG00000188171), ZNF431 (ENSG00000196705), ZNF100 (ENSG00000197020), ZNF257 (ENSG00000197134), ZNF98 (ENSG00000197360), ZNF675 (ENSG00000197372), ZNF273 (ENSG00000198039), ZNF737 (ENSG00000237440), ZNF253 (ENSG00000256771), ZNF723 (ENSG00000268696)
Protein
Protein identifiers
Zinc finger protein 41 homolog — Q8N8Y5 (reviewed: Q8N8Y5)
All UniProt accessions (1): Q8N8Y5
UniProt curated annotations — full annotation on UniProt →
Function. A putative DNA-binding regulatory protein associated with meiosis in spermatogenesis.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001258085, NP_776193* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF13894
UniProt features (8 total): zinc finger region 4, compositionally biased region 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N8Y5-F1 | 69.62 | 0.10 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 82 (showing top):
MODULE_255, MODULE_317, GOBP_MALE_GAMETE_GENERATION, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, MODULE_342, MODULE_69, NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP, chr8q24, MODULE_37, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP, CEBPZ_TARGET_GENES
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
624 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZFP41 | C16orf87 | Q6PH81 | 446 |
| ZFP41 | WFDC6 | Q9BQY6 | 419 |
| ZFP41 | BTBD19 | C9JJ37 | 370 |
| ZFP41 | ZNF428 | Q96B54 | 358 |
| ZFP41 | FAM90A1 | Q86YD7 | 358 |
| ZFP41 | HCFC1R1 | Q9NWW0 | 348 |
| ZFP41 | TEX13C | A0A0J9YWL9 | 348 |
| ZFP41 | ANGEL2 | Q5VTE6 | 322 |
| ZFP41 | RBM34 | P42696 | 320 |
| ZFP41 | GON4L | Q3T8J9 | 276 |
| ZFP41 | SCGB1D1 | O95968 | 270 |
| ZFP41 | TMEM204 | Q9BSN7 | 270 |
| ZFP41 | CREBL2 | O60519 | 257 |
| ZFP41 | TTYH3 | Q9C0H2 | 253 |
| ZFP41 | FIGNL1 | Q6PIW4 | 253 |
IntAct
27 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZFP41 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRTAP10-7 | ZFP41 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP41 | ZNF485 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP91 | ZFP41 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP41 | LLPH | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP41 | UBL5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP41 | SINHCAF | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFAP1 | ZFP41 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP41 | LRP4 | psi-mi:“MI:0914”(association) | 0.530 |
| ZFP41 | AGRN | psi-mi:“MI:0914”(association) | 0.350 |
| ZFP41 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZFP41 | ZNF485 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZFP91 | ZFP41 | psi-mi:“MI:0915”(physical association) | 0.000 |
| UBL5 | ZFP41 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZFP41 | SINHCAF | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZFP41 | LLPH | psi-mi:“MI:0915”(physical association) | 0.000 |
| MFAP1 | ZFP41 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (129): ZC3H4 (Affinity Capture-MS), MRTO4 (Affinity Capture-MS), PYGB (Affinity Capture-MS), PYGL (Affinity Capture-MS), LRP2 (Affinity Capture-MS), LRP1B (Affinity Capture-MS), LRP1 (Affinity Capture-MS), LIMA1 (Affinity Capture-MS), SAFB (Affinity Capture-MS), SAFB2 (Affinity Capture-MS), NOTCH2 (Affinity Capture-MS), RAI14 (Affinity Capture-MS), NELL2 (Affinity Capture-MS), GYS1 (Affinity Capture-MS), SORL1 (Affinity Capture-MS)
ESM2 similar proteins: D3ZUU2, E9Q8T2, G5E8B9, O08954, O35739, O95625, P07665, P10074, P19382, P22227, P25066, P25456, P38621, Q02085, Q02526, Q1H9T6, Q20082, Q3KNW1, Q3MHQ4, Q4VBD9, Q5R633, Q5SVQ8, Q62396, Q65XX7, Q68H95, Q6P2A1, Q7PN68, Q7TS63, Q811F1, Q84MZ4, Q8BIQ3, Q8N8Y5, Q8SW43, Q8T053, Q90625, Q91924, Q95RQ8, Q96C28, Q96MM3, Q99KE8
Diamond homologs: O88553, P0CG23, P17141, P21506, Q02526, Q3ZCX4, Q6ZSS3, Q8N8Y5, Q9UDV6, Q9Y2P0, Q9Y6Q3, P52742, Q6P1L6, A0A9P4XV22, A3KN32, E9Q6W4, O15391, O57311, O62836, O75820, O95863, P08048, P15822, P17010, P17012, P22227, P25490, P28698, P31509, P80944, Q00899, Q01800, Q02026, Q03172, Q0IHB8, Q0VAW7, Q0VCC5, Q29419, Q32NK7, Q3B7M4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
57 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 46 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1139 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:143246915:G:GT | donor_gain | 0.9900 |
| 8:143247234:G:T | donor_gain | 0.9900 |
| 8:143247329:A:T | donor_gain | 0.9900 |
| 8:143249688:A:AG | acceptor_gain | 0.9900 |
| 8:143249689:G:GG | acceptor_gain | 0.9900 |
| 8:143246896:GCTCC:G | donor_gain | 0.9800 |
| 8:143255405:GTT:G | donor_gain | 0.9800 |
| 8:143247250:GCTT:G | donor_gain | 0.9700 |
| 8:143256997:G:GT | donor_gain | 0.9700 |
| 8:143257028:A:G | donor_gain | 0.9700 |
| 8:143246920:G:T | donor_gain | 0.9600 |
| 8:143249689:GC:G | acceptor_gain | 0.9600 |
| 8:143249685:CCCAG:C | acceptor_loss | 0.9400 |
| 8:143249686:CCA:C | acceptor_loss | 0.9400 |
| 8:143249687:CA:C | acceptor_loss | 0.9400 |
| 8:143249688:A:C | acceptor_loss | 0.9400 |
| 8:143249689:G:T | acceptor_loss | 0.9400 |
| 8:143247188:GC:G | donor_gain | 0.9300 |
| 8:143247241:C:T | donor_gain | 0.9300 |
| 8:143248501:A:G | donor_gain | 0.9300 |
| 8:143249689:GCA:G | acceptor_gain | 0.9300 |
| 8:143247138:GCCAG:G | donor_gain | 0.9200 |
| 8:143246916:A:T | donor_gain | 0.9100 |
| 8:143247180:G:GT | donor_gain | 0.9000 |
| 8:143247234:G:GT | donor_gain | 0.9000 |
| 8:143248445:G:GG | donor_gain | 0.9000 |
| 8:143246954:C:G | donor_gain | 0.8900 |
| 8:143248444:A:AG | donor_gain | 0.8900 |
| 8:143247328:G:GT | donor_gain | 0.8800 |
| 8:143246922:C:T | donor_gain | 0.8700 |
AlphaMissense
1328 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:143250297:T:C | F152L | 0.999 |
| 8:143250299:T:A | F152L | 0.999 |
| 8:143250299:T:G | F152L | 0.999 |
| 8:143250381:T:C | F180L | 0.999 |
| 8:143250383:T:A | F180L | 0.999 |
| 8:143250383:T:G | F180L | 0.999 |
| 8:143250213:T:C | F124L | 0.998 |
| 8:143250215:C:A | F124L | 0.998 |
| 8:143250215:C:G | F124L | 0.998 |
| 8:143250254:C:A | H137Q | 0.996 |
| 8:143250254:C:G | H137Q | 0.996 |
| 8:143250326:T:A | H161Q | 0.996 |
| 8:143250326:T:G | H161Q | 0.996 |
| 8:143250328:A:C | Q162P | 0.996 |
| 8:143250129:T:C | F96L | 0.995 |
| 8:143250131:T:A | F96L | 0.995 |
| 8:143250131:T:G | F96L | 0.995 |
| 8:143250160:A:C | Q106P | 0.995 |
| 8:143250242:C:A | H133Q | 0.995 |
| 8:143250242:C:G | H133Q | 0.995 |
| 8:143250338:C:A | H165Q | 0.995 |
| 8:143250338:C:G | H165Q | 0.995 |
| 8:143250154:G:C | R104P | 0.994 |
| 8:143250158:T:A | H105Q | 0.994 |
| 8:143250158:T:G | H105Q | 0.994 |
| 8:143250170:C:A | H109Q | 0.994 |
| 8:143250170:C:G | H109Q | 0.994 |
| 8:143250297:T:A | F152I | 0.994 |
| 8:143250381:T:A | F180I | 0.994 |
| 8:143250214:T:C | F124S | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000127547 (8:143248826 T>A), RS1000283836 (8:143258012 A>G,T), RS1000313555 (8:143252262 G>A), RS1000354130 (8:143248212 G>A), RS1000580424 (8:143252485 G>A), RS1000657695 (8:143246491 T>G), RS1000827676 (8:143247010 A>C,G), RS1000861294 (8:143261064 G>A), RS1000949631 (8:143247350 G>T), RS1001058873 (8:143261279 G>A), RS1001093006 (8:143247162 C>G,T), RS1001148311 (8:143252122 G>C), RS1001275705 (8:143259144 G>A), RS1001306173 (8:143249418 G>A), RS1001441449 (8:143249194 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008070_105 | HDL cholesterol levels | 2.000000e-06 |
| GCST008070_26 | HDL cholesterol levels | 2.000000e-10 |
| GCST008075_115 | HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 7.000000e-16 |
| GCST008075_61 | HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 9.000000e-12 |
| GCST008084_21 | HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 8.000000e-13 |
| GCST008084_231 | HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 8.000000e-18 |
| GCST008085_156 | HDL cholesterol levels in current drinkers | 2.000000e-09 |
| GCST008085_24 | HDL cholesterol levels in current drinkers | 1.000000e-12 |
| GCST012227_45 | Hip circumference adjusted for BMI | 8.000000e-09 |
| GCST012227_46 | Hip circumference adjusted for BMI | 1.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0004329 | alcohol drinking |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases expression, increases methylation | 4 |
| Air Pollutants | affects expression, increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| manganese chloride | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| bisphenol S | increases methylation | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Manganese | increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Oxygen | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Quercetin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD06 | HEK293 eGFP-ZFP41 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.